IFN-γ released by immunotherapy-activated CD8+T cells down-regulates the expression of SLC3A2 and SLC7A11, inhibits cystine uptake in cancer cells, and enhances ferroptosis specific lipid peroxidation in tumor cells (50). The gene discussed is IFNG; the disease is neoplasm.